Skip to content

Safety check of cosmetic products

Evaluation of irritation potential of Skin Care formulations on healthy human subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070376
Enrollment
26
Registered
2024-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Scabisin Soap (S00424002): 8% w/w solution of the investigational products will be prepared. 40 microliters of prepared solution is dispensed on aluminium finn chambers and then be tape

Sponsors

Torque Pharmaceuticals P LTD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Female and male Asian Indian subjects. 2) Healthy human subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up) 3) Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)

Exclusion criteria

Exclusion criteria: 1 For female Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2 Having refused to give his or her assent by not signing the consent form 3 Taking part in another study liable to interfere with this study 4 Being diabetic. 5 Being asthmatic. 6 Following a chronic medicinal treatment 7 Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin). 8 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 9 Having undergone a surgery requiring a general anaesthesia of more than one hour in the past 6 months. 10 Having changed his or her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.

Design outcomes

Primary

MeasureTime frame
Dermatological safety on skinTimepoint: Baseline,0 hrs,24 hrs and 8 days

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

Mascot Spincontrol India Pvt. Ltd.

investigators@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026